Back to search results

CardioHeartConnect: Digital Cardiac Rehab for Aortic Valve Conditions

This study, called CardioHeartConnect, is looking at whether a digital cardiac rehabilitation program using the Peloton app can help people recovering from transcatheter aortic valve replacement (TAVR) for aortic valve stenosis or disease. You would either use the CardioHeartConnect program, which includes daily short exercises like walking and yoga, or receive weekly educational materials (CardioHeartEd). The study aims to see if the Peloton program improves your physical activity, how well you can do daily tasks, and your overall quality of life. About 200 people will join, and you would need to be able to speak English and stand with or without help. The study will measure your physical activity using steps at 8 weeks and 12 months.

Study design
This is an interventional study with 200 participants. You would be randomly assigned to one of two groups: CardioHeartConnect or CardioHeartEd.
What's involved
You would participate in an eight-week program, either with daily modules or weekly educational resources. You will be assessed at the beginning, at 8 weeks, and at 12 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 12 months after starting the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07008911

CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation

Recruiting
NAAges 18+InterventionalTreatment
University of Colorado, Denver
~200 participants
Updated 2026-08-03 on ClinicalTrials.gov
What's tested:CardioHeartConnectCardioHeartEd

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in physical activity measured by average daily steps
Measured over Baseline to 8 weeks (Primary); 8 weeks, and 12 months (Secondary)

Conditions

Aortic Valve Stenosis
Aortic Valve Disease

Explore related trials

Aortic Valve Stenosis

Where it's being run

1 sites across 1 states
Colorado1

Study leadership

  • Jennifer Portz, PhD, MSW · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver
  • Christopher Knoepke, PhD, MSW · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver

Who to contact

Joshua Rosen
[email protected]
303-724-1889
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Appropriate for cardiac rehabilitation (CR) referral, as determined by the UCHealth Structural Heart \& Valve Clinic team
Community-dwelling
Reside in the United States
Able to speak and understand English
Able to provide informed consent
Able to stand with or without an assistive device
Able to see and hear content on the Peloton App via phone, tablet, or computer

What this trial measures

  • Change in physical activity measured by average daily stepsBaseline to 8 weeks (Primary); 8 weeks, and 12 months (Secondary)

    Change in mean daily steps from baseline to 8 weeks, measured using smartwatch accelerometer data collected through the Ortus platform. Steps will serve as the primary endpoint to evaluate the effect of CardioHeartConnect compared with control.